Equity Capital And Reserves Cambio Fecha
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Cara Therapeutics USD 85.64M 23.29M 2023-09
Corcept Therapeutics USD 506.7M 45.03M 2023-12
Cytokinetics USD -386323000 52.48M 2023-12
Eisai JPY 861.67B 16.8B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
J&J USD 71.23B 3.92B 2023-09
Marinus Pharmaceuticals USD 54.54M 2.8M 2023-09
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vanda Pharmaceuticals USD 539.9M 4.16M 2023-06
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Acadia Pharmaceuticals Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.